These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20946884)

  • 1. Effect of collagen I and fibronectin on the adhesion, elasticity and cytoskeletal organization of prostate cancer cells.
    Docheva D; Padula D; Schieker M; Clausen-Schaumann H
    Biochem Biophys Res Commun; 2010 Nov; 402(2):361-6. PubMed ID: 20946884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mineralized human primary osteoblast matrices as a model system to analyse interactions of prostate cancer cells with the bone microenvironment.
    Reichert JC; Quent VM; Burke LJ; Stansfield SH; Clements JA; Hutmacher DW
    Biomaterials; 2010 Nov; 31(31):7928-36. PubMed ID: 20688384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism.
    Franzen CA; Amargo E; Todorović V; Desai BV; Huda S; Mirzoeva S; Chiu K; Grzybowski BA; Chew TL; Green KJ; Pelling JC
    Cancer Prev Res (Phila); 2009 Sep; 2(9):830-41. PubMed ID: 19737984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High dose fractionated ionizing radiation inhibits prostate cancer cell adhesion and beta(1) integrin expression.
    Simon EL; Goel HL; Teider N; Wang T; Languino LR; Fitzgerald TJ
    Prostate; 2005 Jun; 64(1):83-91. PubMed ID: 15651037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of GFP-actin expression on the adhesion dynamics of HepG2 cells on a model extracellular matrix.
    Feng Z; Ning Chen W; Vee Sin Lee P; Liao K; Chan V
    Biomaterials; 2005 Sep; 26(26):5348-58. PubMed ID: 15814133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type I collagen receptor (alpha 2 beta 1) signaling promotes the growth of human prostate cancer cells within the bone.
    Hall CL; Dai J; van Golen KL; Keller ET; Long MW
    Cancer Res; 2006 Sep; 66(17):8648-54. PubMed ID: 16951179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin inhibits cell motility and alters microfilament organization and function in prostate cancer cells.
    Holy J
    Cell Motil Cytoskeleton; 2004 Aug; 58(4):253-68. PubMed ID: 15236356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing the interaction forces of prostate cancer cells with collagen I and bone marrow derived stem cells on the single cell level.
    Sariisik E; Docheva D; Padula D; Popov C; Opfer J; Schieker M; Clausen-Schaumann H; Benoit M
    PLoS One; 2013; 8(3):e57706. PubMed ID: 23472100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
    Nemeth JA; Harb JF; Barroso U; He Z; Grignon DJ; Cher ML
    Cancer Res; 1999 Apr; 59(8):1987-93. PubMed ID: 10213511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AFM indentation study of breast cancer cells.
    Li QS; Lee GY; Ong CN; Lim CT
    Biochem Biophys Res Commun; 2008 Oct; 374(4):609-13. PubMed ID: 18656442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of matrix elasticity on the maintenance of the chondrogenic phenotype.
    Schuh E; Kramer J; Rohwedel J; Notbohm H; Müller R; Gutsmann T; Rotter N
    Tissue Eng Part A; 2010 Apr; 16(4):1281-90. PubMed ID: 19903088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis.
    Mochizuki H; Matsubara A; Teishima J; Mutaguchi K; Yasumoto H; Dahiya R; Usui T; Kamiya K
    Biochem Biophys Res Commun; 2004 Jul; 320(3):656-63. PubMed ID: 15240098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRMS1 expression alters the ultrastructural, biomechanical and biochemical properties of MDA-MB-435 human breast carcinoma cells: an AFM and Raman microspectroscopy study.
    Wu Y; McEwen GD; Harihar S; Baker SM; DeWald DB; Zhou A
    Cancer Lett; 2010 Jul; 293(1):82-91. PubMed ID: 20083343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shape-engineered fibroblasts: cell elasticity and actin cytoskeletal features characterized by fluorescence and atomic force microscopy.
    Kidoaki S; Matsuda T
    J Biomed Mater Res A; 2007 Jun; 81(4):803-10. PubMed ID: 17226810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAR1-mediated RhoA activation facilitates CCL2-induced chemotaxis in PC-3 cells.
    Loberg RD; Tantivejkul K; Craig M; Neeley CK; Pienta KJ
    J Cell Biochem; 2007 Aug; 101(5):1292-300. PubMed ID: 17492768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of core 2 beta1,6-N-acetylglucosaminyltransferase facilitates prostate cancer progression.
    Hagisawa S; Ohyama C; Takahashi T; Endoh M; Moriya T; Nakayama J; Arai Y; Fukuda M
    Glycobiology; 2005 Oct; 15(10):1016-24. PubMed ID: 15932919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential adhesion of prostate cancer cells to bone is mediated by binding to bone marrow endothelial cells as compared to extracellular matrix components in vitro.
    Cooper CR; McLean L; Walsh M; Taylor J; Hayasaka S; Bhatia J; Pienta KJ
    Clin Cancer Res; 2000 Dec; 6(12):4839-47. PubMed ID: 11156243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and functional role of CCR9 in prostate cancer cell migration and invasion.
    Singh S; Singh UP; Stiles JK; Grizzle WE; Lillard JW
    Clin Cancer Res; 2004 Dec; 10(24):8743-50. PubMed ID: 15623660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulating cell adhesion dynamics on carbon nanotube monolayer engineered with extracellular matrix proteins.
    Cai N; Wong CC; Gong YX; Tan SC; Chan V; Liao K
    ACS Appl Mater Interfaces; 2010 Apr; 2(4):1038-47. PubMed ID: 20423124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The androgen receptor and prostate cancer invasion.
    Bonaccorsi L; Muratori M; Marchiani S; Forti G; Baldi E
    Mol Cell Endocrinol; 2006 Feb; 246(1-2):157-62. PubMed ID: 16376012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.